Guggenheim Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.47M | Buy |
11,848
+11
| +0.1% | +$3.62K | 0.03% | 533 |
|
|
2025
Q4 | $4.15M | Sell |
11,837
-3,524
| -23% | -$1.19M | 0.03% | 479 |
|
|
2025
Q3 | $4.96M | Sell |
15,361
-1,498
| -9% | -$466K | 0.04% | 444 |
|
|
2025
Q2 | $6.56M | Sell |
16,859
-1,303
| -7% | -$524K | 0.05% | 355 |
|
|
2025
Q1 | $7.9M | Sell |
18,162
-831
| -4% | -$334K | 0.07% | 299 |
|
|
2024
Q4 | $7.01M | Sell |
18,993
-1,353
| -7% | -$566K | 0.06% | 350 |
|
|
2024
Q3 | $10.6M | Sell |
20,346
-3,103
| -13% | -$1.66M | 0.07% | 292 |
|
|
2024
Q2 | $12.7M | Buy |
23,449
+1,662
| +8% | +$879K | 0.09% | 236 |
|
|
2024
Q1 | $11.3M | Buy |
21,787
+7,859
| +56% | +$3.91M | 0.08% | 284 |
|
|
2023
Q4 | $6.57M | Sell |
13,928
-846
| -6% | -$391K | 0.05% | 442 |
|
|
2023
Q3 | $6.43M | Buy |
14,774
+7,220
| +96% | +$3.27M | 0.06% | 411 |
|
|
2023
Q2 | $3.36M | Buy |
7,554
+17
| +0.2% | +$7.84K | 0.03% | 671 |
|
|
2023
Q1 | $3.47M | Buy |
7,537
+744
| +11% | +$354K | 0.03% | 650 |
|
|
2022
Q4 | $3.48M | Buy |
6,793
+920
| +16% | +$467K | 0.03% | 651 |
|
|
2022
Q3 | $2.67M | Sell |
5,873
-5,703
| -49% | -$2.73M | 0.02% | 732 |
|
|
2022
Q2 | $5.59M | Sell |
11,576
-7,278
| -39% | -$3.6M | 0.04% | 494 |
|
|
2022
Q1 | $9.26M | Sell |
18,854
-829
| -4% | -$379K | 0.06% | 418 |
|
|
2021
Q4 | $9.12M | Sell |
19,683
-2,148
| -10% | -$904K | 0.05% | 463 |
|
|
2021
Q3 | $8.14M | Sell |
21,831
-2,771
| -11% | -$1.05M | 0.05% | 458 |
|
|
2021
Q2 | $9.39M | Sell |
24,602
-2,573
| -9% | -$983K | 0.06% | 417 |
|
|
2021
Q1 | $9.75M | Buy |
27,175
+3,789
| +16% | +$1.22M | 0.06% | 377 |
|
|
2020
Q4 | $7.51M | Buy |
23,386
+5,223
| +29% | +$1.6M | 0.05% | 424 |
|
|
2020
Q3 | $4.88M | Buy |
18,163
+3,671
| +25% | +$988K | 0.04% | 540 |
|
|
2020
Q2 | $3.81M | Buy |
14,492
+5,135
| +55% | +$1.37M | 0.03% | 626 |
|
|
2020
Q1 | $2.12M | Sell |
9,357
-7,342
| -44% | -$2M | 0.02% | 765 |
|
|
2019
Q4 | $5.04M | Sell |
16,699
-4,247
| -20% | -$1.17M | 0.04% | 628 |
|
|
2019
Q3 | $5.03M | Sell |
20,946
-2,839
| -12% | -$778K | 0.04% | 593 |
|
|
2019
Q2 | $6.71M | Sell |
23,785
-467
| -2% | -$128K | 0.05% | 450 |
|
|
2019
Q1 | $6.96M | Sell |
24,252
-10,876
| -31% | -$3.15M | 0.06% | 441 |
|
|
2018
Q4 | $9.22M | Buy |
35,128
+5,322
| +18% | +$1.46M | 0.08% | 292 |
|
|
2018
Q3 | $8.17M | Sell |
29,806
-3,024
| -9% | -$785K | 0.05% | 445 |
|
|
2018
Q2 | $7.82M | Sell |
32,830
-177,920
| -84% | -$41.2M | 0.05% | 446 |
|
|
2018
Q1 | $46.3M | Sell |
210,750
-12,234
| -5% | -$2.87M | 0.11% | 367 |
|
|
2017
Q4 | $50.2M | Sell |
222,984
-142,707
| -39% | -$30.4M | 0.12% | 332 |
|
|
2017
Q3 | $69.4M | Buy |
365,691
+2,161
| +0.6% | +$411K | 0.16% | 117 |
|
|
2017
Q2 | $68.4M | Sell |
363,530
-2,748
| -0.8% | -$494K | 0.18% | 119 |
|
|
2017
Q1 | $60.6M | Buy |
366,278
+8,517
| +2% | +$1.35M | 0.16% | 164 |
|
|
2016
Q4 | $51.4M | Buy |
357,761
+7,286
| +2% | +$976K | 0.15% | 205 |
|
|
2016
Q3 | $43.9M | Sell |
350,475
-4,590
| -1% | -$593K | 0.14% | 230 |
|
|
2016
Q2 | $46.6M | Buy |
355,065
+15,708
| +5% | +$2.15M | 0.15% | 199 |
|
|
2016
Q1 | $47.2M | Sell |
339,357
-52,554
| -13% | -$7.02M | 0.15% | 181 |
|
|
2015
Q4 | $54.6M | Buy |
391,911
+13,152
| +3% | +$1.81M | 0.16% | 152 |
|
|
2015
Q3 | $53M | Sell |
378,759
-70,176
| -16% | -$10.5M | 0.16% | 126 |
|
|
2015
Q2 | $73.7M | Sell |
448,935
-8,674
| -2% | -$1.39M | 0.18% | 89 |
|
|
2015
Q1 | $70.7M | Sell |
457,609
-28,462
| -6% | -$4.05M | 0.17% | 114 |
|
|
2014
Q4 | $61.1M | Sell |
486,071
-170,947
| -26% | -$21.1M | 0.15% | 144 |
|
|
2014
Q3 | $78.6M | Sell |
657,018
-8,571
| -1% | -$983K | 0.19% | 81 |
|
|
2014
Q2 | $71.6M | Buy |
665,589
+110,523
| +20% | +$11.4M | 0.18% | 90 |
|
|
2014
Q1 | $55.3M | Buy |
555,066
+44,435
| +9% | +$4.02M | 0.16% | 124 |
|
|
2013
Q4 | $47.2M | Buy |
510,631
+101,720
| +25% | +$9.04M | 0.14% | 150 |
|
|
2013
Q3 | $34.2M | Buy |
408,911
+74,424
| +22% | +$6.38M | 0.12% | 183 |
|
|
2013
Q2 | $27.4M | Buy |
+334,487
| New | +$25M | 0.12% | 198 |
|
Other funds holding ELV
VCM
VPM
Guggenheim Capital's ELV Position: Q1 2026 in Review
Guggenheim Capital increased its Elevance Health (ELV) stake by 0.09% in Q1 2026, buying an estimated $3.62K and bringing the position to 11,848 shares worth $3.47M. The position accounts for 0.03% of the portfolio, ranked #533.
Guggenheim Capital first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $78.6M in Q3 2014. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Guggenheim Capital held 11,848 shares of Elevance Health worth $3.47M as of Q1 2026.
- Guggenheim Capital bought 11 Elevance Health shares in Q1 2026, an estimated $3.62K.
- Elevance Health made up 0.03% of Guggenheim Capital's portfolio in Q1 2026, its #533 holding.
- Guggenheim Capital first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Guggenheim Capital's Elevance Health position peaked at $78.6M in Q3 2014.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.